ArticleJournal of gastrointestinal cancer2021
Epidemiology of Gastric Cancer in North Africa and the Middle East from 1990 to 2017.
Article in Journal of gastrointestinal cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 18 citations in OpenAlex.
- Prevalence, Risk Factors, and Endoscopic Findings ofAntibiotics (Basel, Switzerland) · 2025Article
- Clinical presentation and treatment outcomes of gastric adenocarcinoma patients: a retrospective study from Ain Shams Clinical Oncology Department.Ecancermedicalscience · 2025Article
- Utilization of a Joint Point Regression Model for Predicting Mortality Rates of Common Cancers in Babol City.Cancer reports (Hoboken, N.J.) · 2025Article
- Article
- The Trend of Years of Life Lost due to Gastrointestinal Cancers in Fars (Iran) 2004-2019.Iranian journal of public health · 2024Article
- Epidemiological features of tuberculosis in the Middle East and North Africa from 1990 to 2019: results from the global burden of disease Study 2019.African health sciences · 2023Article
- Prevalence of Her2-neu status and its clinicopathological association in newly diagnosed gastric cancer patients.BMC cancer · 2022Article
- Development of a prognostic metabolic signature in stomach adenocarcinoma.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2022Article
- A retrospective analysis based on multiple machine learning models to predict lymph node metastasis in early gastric cancer.Frontiers in oncology · 2022Article
- Clinical Significance of Composition Changes in T-cell Subpopulations After Chemotherapy in Patients With Gastric Cancer.In vivo (Athens, Greece)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
Abstract
introductionGastric cancer is the fifth most common cancer worldwide and the third cause of cancer deaths and disability-adjusted life years (DALYs) worldwide. The countries of the Middle East and North Africa are similar in many determinants of health, but there are significant differences in the incidence of gastric cancer in these countries. Therefore, the purpose of this study was to compare the burden of gastric cancer in MENA countries with appropriate policies to reduce the incidence and mortality of gastric cancer in the region. MATERIALS AND
methodsGBD database data were used to assess the gastric cancer indices in MENA countries consisted of 21 countries in the Middle East and North Africa in 1900 and 2017. Gastric cancer-related analysis using DALY counts, which is the sum of YLLs (total years lost due to premature death) and YLDs (years lost due to disability), and incidence rates, prevalence rates, death rates, and standardized age rates (ASR) were measured.
resultsThe incidence of gastric cancer has decreased in the world and the MENA region from 1990 to 2017, which is higher than the global average in MENA. But death rates in the region have decreased below the global average. The trend of changes in DALY count has increased from 1990 to 2017 in all countries in the region except Turkey. This increase is higher in men than in women and also in Iran. In these countries, the highest percentage of total DALY of gastric cancer is attributable to the risk factors for high sodium and cigarette consumption, in Turkey and the United Arab Emirates, respectively (from 1990 to 2017) Also, the largest decrease is in the UAE and Iraq, respectively.
conclusionDespite a decrease in the incidence of gastric cancer and, possibly, due to late diagnosis and poor health services, the attenuation of gastric cancer is high in MENA countries. Therefore, it is recommended to reduce the attenuation of screening programs before 50 years old for early detection in addition to prevention programs and to reduce smoking, especially in men.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.